Gastrointestinal Cancer News

A single dose of aspirin did not help improve the sensitivity of fecal immunochemical testing for adults undergoing colorectal cancer screening, according to a study published in JAMA.

Patients who undergo complex cancer surgery at hospitals affiliated with top-ranked cancer centers have a significantly higher risk for mortality than patients who undergo such surgeries at the flagship institutions, according to research published in JAMA Network Open.

High levels of cardiorespiratory fitness appeared associated with reduced risk for lung and colorectal cancer, as well as lower risk for death after diagnosis with these cancers, according to study results published in Cancer.

Johns Hopkins University School of Medicine researchers have developed an assay designed to screen for esophageal cancer.

Vitamin D3 supplementation moderately prolonged PFS and, to a limited extent, RFS among patients with certain gastrointestinal cancers, according to results of two separate studies published in JAMA.

DESTIN, Fla. — Patients with gout are 50% more likely to develop cancer, with prostate cancer being the most common among that population, according to a presenter at the North American Young Rheumatology Investigator Forum.

A $25 million grant from Cancer Research UK will fund a project that aims to discover how certain microbes lead to colorectal cancer and influence response to treatment, according to a press release.

A regimen of encorafenib, binimetinib and cetuximab demonstrated acceptable safety and tolerability among patients with previously treated BRAF V600E-mutant metastatic colorectal cancer in the safety lead-in of the randomized, phase 3 BEACON trial, according to results published in Journal of Clinical Oncology.

Many patients with stage IV metastatic cancer who died within a month of diagnosis received cancer-related treatment, according to study in JNCI Cancer Spectrum.

Hyperprogressive disease did not appear to be related to clinically significant adverse events, age, tumor type or type of immunotherapy among patients with solid tumors in early-phase trials, according to results of a retrospective study published in Cancer.